NexMed Announces Pre-Clinical Results Showing That Its Proprietary Calcipotriene Betamethasone Psoriasis Formulation …

NexMed Announces Pre-Clinical Results Showing That Its Proprietary Calcipotriene Betamethasone Psoriasis Formulation … SAN DIEGO—-NexMed, Inc. , a specialty CRO with a pipeline of products based on the NexACT® technology, today announced results from a pre-clinical study showing that calcipotriene 0.005% and betamethasone dipropionate 0.064%, when formulated with NexACT®, results in a topical treatment which [...]

Study Shows That Daivobet ® is Very Effective Against Severe Psoriasis

Psoriasis medicine Daivobet ® has a new study been  proved to be equally effective for treatment of severe psoriasis as the treatment of mild and moderate psoriasis. Daivobet ® combines calcipotriol and betamethasone dipropionate. The patented formulation allows patients to benefit from both active ingredients therapeutic effect. The first Daivobet ® studies showed that patients [...]